Supriya Lifescience, Plasma Nutrition collaborate on protein technology

To bring the optimized protein into the Indian market

Supriya Lifescience Ltd, a Mumbai-based company specializing in active pharmaceutical ingredients (API), announces its recent collaboration with Plasma Nutrition, Inc, a United States-based company known for innovative consumer products located in Delaware. The strategic partnership involves an exclusive technology licensing agreement, granting Supriya Lifescience Ltd the sole rights for manufacturing and marketing Ingredient Optimized Protein (ioProtein) in India.

The primary purpose of this collaboration is to bring the optimized protein into the Indian market. ioProtein is a patented process (patent pending in the US). This revolutionary protein powder is designed for use as protein supplements and boasts a significant advantage, and it is highly bioavailable. This means that higher amounts of proteins are absorbed quickly by the body, providing consumers with a more effective and efficient protein supplement.

During the term of the agreement, Supriya Lifescience Ltd will lead the manufacturing and marketing of ioProtein in India. This marks the introduction of a new category of protein powders in the Indian market, and it is relatively healthier compared to other popular protein powders available through various Gyms, general stores, and digital marketing channels.

Dr Saloni Wagh, Executive Director at Supriya Lifescience Ltd., said, “This strategic partnership represents our commitment to providing high-nutrition solutions to consumers in India. With ioProtein’s high bioavailability and its unmatched advantage, we are confident that the ‘IO’ technology will revolutionize the nutrition industry and become the preferred choice for health-conscious individuals.”